RACTHERA Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 114

Employees

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

RACTHERA General Information

Description

Developer of iPS cell-derived regenerative medicine designed for the treatment of diseases with lost physiological functions. The company's technology utilizes allogeneic iPS cell-derived dopaminergic neural progenitor cells and retinal sheets, providing the healthcare sector with innovative therapies to restore physiological functions in patients with previously untreatable conditions.

Contact Information

Website
www.racthera.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1-7-1 Nihonbashi 2-chome
  • Chuo-ku, Tokyo 103-6012
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • 1-7-1 Nihonbashi 2-chome
  • Chuo-ku, Tokyo 103-6012
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RACTHERA Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RACTHERA‘s full profile, request access.

Request a free trial

RACTHERA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RACTHERA Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RACTHERA‘s full profile, request access.

Request a free trial

RACTHERA FAQs

  • When was RACTHERA founded?

    RACTHERA was founded in 2024.

  • Where is RACTHERA headquartered?

    RACTHERA is headquartered in Chuo-ku, Japan.

  • What is the size of RACTHERA?

    RACTHERA has 114 total employees.

  • What industry is RACTHERA in?

    RACTHERA’s primary industry is Biotechnology.

  • Is RACTHERA a private or public company?

    RACTHERA is a Private company.

  • What is RACTHERA’s current revenue?

    The current revenue for RACTHERA is .

  • Who are RACTHERA’s investors?

    Sumitomo Chemical and Sumitomo Pharma have invested in RACTHERA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process